Bayesian models identify specific lymphoproliferative disorders associated with hepatitis C virus infection

International Journal of Cancer

Volumn 124, Issue 9, 2009, Pages 2246-2249

  Arcaini, Luca ^a   Pascutto, Cristiana ^a   Passamonti, Francesco ^a   Bruno, Raffaele ^a   Merli, Michele ^a   Rizzi, Silvia ^a   Orlandi, Ester ^a   Astori, Cesare ^a   Rattotti, Sara ^a   Paulli, Marco ^a   Lazzarino, Mario ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL LYMPHOMA; BAYES THEOREM; CANCER CLASSIFICATION; CARCINOGENESIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HAIRY CELL LEUKEMIA; HEPATITIS C; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; LARGE CELL LYMPHOMA; LETTER; LIVER CIRRHOSIS; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PREVALENCE; PRIORITY JOURNAL; SEROLOGY; ADOLESCENT; ADULT; AGED; FEMALE; HEPATITIS C VIRUS; ISOLATION AND PURIFICATION; LYMPHOPROLIFERATIVE DISEASE; MALE; MIDDLE AGED; PATHOLOGY; RISK FACTOR; VIROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BAYES THEOREM; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 63449101607     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24162     Document Type: Letter

References (23)

1. Saadoun D, Landau DA, Calabrese LH, Cacoub PP. Hepatitis Cassociated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation. Rheumatology 2007;46: 1234-1242 (Pubitemid 47244492)
2. Isaacson PG. Update on MALT lymphomas. Best Pract Res Clin Haematol 2005;18:57-68. (Pubitemid 40197865)
3. Hermine O, Lefrère F, Bronowicki JP, Mariette X, Jondeau K, Eclache- Saudreau V, Delmas B, Valensi F, Cacoub P, Brechot C, Varet B, Troussard X. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002;347:89-94. (Pubitemid 34753478)
4. Vallisa D, Bernuzzi P, Arcaini L, Sacchi S, Callea V, Marasca R, Lazzaro A, Trabacchi E, Anselmi E, Arcari AL, Moroni C, Bertè R, et al. Role of anti-hepatitis C virus (HCV) treatment in HCV-related, lowgrade B-cell, non-Hodgkin's lymphoma: a multicenter. Italian experience. J Clin Oncol 2005;23:468-473
5. Saadoun D, Suarez F, Lefrere F, Valensi F, Mariette X, Aouba A, Besson C, Varet B, Troussard X, Cacoub P, Hermine O. Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity? Blood 2005; 105:74-76
6. Dal Maso L, Franceschi S. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev 2006;11:2078-2085
7. Nieters A, Kallinowski B, Brennan P, Ott M, Maynadié M, Benavente Y, Foretova L, Cocco PL, Staines A, Vornanen M, Whitby D, Boffetta P, et al. Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH. Gastroenterology 2006; 131:1879-1886.
8. de Sanjose S, Benavente Y, Vajdic CM, Engels EA, Morton LM, Bracci PM, Spinelli JJ, Zheng T, Zhang Y, Franceschi S, Talamini R, Holly EA, et al. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol 2008;6:451-458
9. Suarez F, Lortholary O, Hermine O, Lecuit M. Infection-associated lymphomas derived from marginal-zone B-cells: a model of antigendriven lymphoproliferations. Blood 2006;107:3034-3044
10. Arcaini L, Lazzarino M, Colombo N, Burcheri S, Boveri E, Paulli M, Morra E, Gambacorta M, Cortelazzo S, Tucci A, Ungari M, Ambrosetti A, et al. Splenic marginal zone lymphoma: a prognostic model for clinical use. Blood 2006;107:4643-4649
11. Arcaini L, Burcheri S, Rossi A, Paulli M, Bruno R, Passamonti F, Brusamolino E, Molteni A, Pulsoni A, Cox MC, Orsucci L, Fabbri A, et al. Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT. Ann Oncol 2007;18:346-350
12. Ferreri AJ, Viale E, Guidoboni M, Resti AG, De Conciliis C, Politi L, Lettini AA, Sacchetti F, Dolcetti R, Doglioni C, Ponzoni M. Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa. Ann Oncol 2006;17:769-772
13. Arcaini L, Paulli M, Burcheri S, Rossi A, Spina M, Passamonti F, Lucioni M, Motta T, Canzonieri V, Montanari M, Bonoldi E, Gallamini A, et al. Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease. Br J Haematol 2007;136:301-304
14. Tomita N, Kodama F, Takabayashi M, Kawano T, Yamaji S, Fujimaki K, Fujisawa S, Kanamori H, Motomura S, Ishigatsubo Y. Clinical features and outcome in HCV-positive aggressive non-Hodgkin's lymphoma. Leuk Lymphoma 2003;44:1159-1164 (Pubitemid 36609109)
15. Besson C, Canioni D, Lepage E, Pol S, Morel P, Lederlin P, Van Hoof A, Tilly H, Gaulard P, Coiffier B, Gisselbrecht C, Brousse N, et al. Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive in LNH 93 and LNH 98 groupe d'etude des lymphomas de l'adulte programs. J Clin Oncol 2006;24:953-960
16. Visco C, Arcaini L, Brusamolino E, Burcheri S, Ambrosetti A, Merli M, Bonoldi E, Chilosi M, Viglio A, Lazzarino M, Pizzolo G, Rodeghiero F. Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: analysis of 156 patients from northern Italy. Ann Oncol 2006;17:1434-1440 (Pubitemid 44400383)
17. Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, Jack A, Cozen W, Maynadié M, Spinelli JJ, Costantini AS, Rüdiger T, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007;110:695-708.
18. Matutes E, Owusu-Ankomah K, Morilla R, Garcia Marco J, Houlihan A, Que TH, Catovsky D. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994;8:1640-1645 (Pubitemid 24323778)
19. Ugo V, Leporrier N, Salaun V, Letestu R, Radford-Weiss I, Ramond S, Nataf J, Guesnu M, Picard F, Brouzes C, Perrot JY, Valensi F, et al. Deciphering leukemic B-cell chronic lymphoproliferative disorders. Leuk Lymphoma 2006;47:2088-2095
20. Goldaniga M, Ferrario A, Cortelazzo S, Guffanti A, Pavone E, Ambrosetti A, Marcheselli L, Rossi F, Luminari S, Rossi A, Cro L, Federico M, et al. A multicenter retrospective clinical study of CD5/ CD10-negative chronic B cell leukemias. Am J Hematol 2008;83: 349-354
21. Spiegelhalter DJ, Best NG, Carlin BP, Van der Linde A. Bayesian measures of model complexity and fit (with discussion). Journal of the Royal Statistical Society, Series B, 2002;64:583-616.
22. Gilks WR, Richardson S, Spiegelhalter DJ, eds. Markov chain Monte Carlo in practice. London: Chapman & Hall, 1996.
23. Spiegelhalter DJ, Thomas A, Best N, Lunn D. WinBUGS user manual, Version 1.4. Cambridge, UK: MRC Biostatistics Unit, 2002.